Larkin Finbar 4
4 · Jazz Pharmaceuticals plc · Filed Nov 16, 2022
Insider Transaction Report
Form 4
Larkin Finbar
SVP, Technical Development
Transactions
- Sale
Ordinary Shares
2022-11-14$149.33/sh−197$29,418→ 19,409 total
Footnotes (1)
- [F1]Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.